Is Stock Rover worth paying for? Costs, limits and who it suits
Stock Rover is worth considering when detailed screening and portfolio analysis are tasks you perform regularly. Its paid plans are harder to justify if you only want an occasional company overview or need broad international company coverage.
This assessment uses public documentation checked on 19 September 2026, with an attributed outside review for usability context. We have not tested its paid tiers. Helmbeam is our product.
Reviewed 20 September 2026
Start with the kind of work you do
Stock Rover documents fundamental screening, financial charting, research reports and portfolio analysis. Its company-research focus is North American securities. Global market information should not be confused with equivalent detailed screening coverage of every overseas exchange.
The product is particularly relevant to a question such as: which companies meet my financial criteria, and how would adding one change the characteristics of the portfolio I already hold? Someone whose question is simply “what does this business do?” may not use much of that capability.
Current published costs
The official subscription FAQ listed these US-dollar prices when checked. An annual charge buys a year; it is not a monthly subscription just because a vendor also shows a monthly equivalent.
| Plan | Monthly subscription | Annual subscription |
|---|---|---|
| Premium | $34 | $348 |
| Premium Plus | $70 | $588 |
| Ultimate | $99 | $948 |
| Ultimate Pro | $199 | $1,788 |
Check taxes, renewal terms and the precise feature table before subscribing. A higher tier may raise limits or add reports you will never use. Choose from a required task, then identify the least expensive tier that actually supports it.
The trial has exceptions
Stock Rover documents a fourteen-day trial without requiring a credit card and a move to its Free service afterward. However, its plans page describes trial restrictions, including CSV export and report quotas. Do not use the phrase “all features free” as a substitute for reading those exceptions.
A useful evaluation would be to recreate one screen you already understand, inspect a familiar company's numbers and check a small portfolio. Record where the interface helps and where you cannot explain an output. A large number of filters is useful only if you understand their definitions.
Separate screening from portfolio decisions
Imagine a hypothetical screen for profitable businesses with manageable debt. Two companies pass, but both depend on the same customer industry. The screen has found candidates; it has not established that holding both provides meaningful diversification.
Portfolio analysis can help expose overlap, concentration and historical relationships. Those relationships can change. Neither a screen result nor a simulation establishes that future losses will stay within a displayed range. Read concentration risk guidance from FINRA alongside the product's explanations.
What an outside review adds
David Rodeck's StockBrokers.com review, dated 14 September 2026, describes hands-on testing and reports both detailed tools and navigation difficulty. That is his experience, not ours. We use it as a reason to test a real workflow rather than claim the interface will feel easy or difficult to everyone.
The same review contains conflicting price figures between its summary and detailed table. For current costs, the vendor's present subscription information is the better reference. A recent date at the top of a review does not ensure every paragraph was updated together.
When another tool may fit better
For international financial-statement research, compare TIKR and Stock Rover. For a browser-based US market screen and visual market scan, compare Finviz and Stock Rover. Neither comparison makes one product universally superior.
If you do not yet know what you want to screen for, first learn a small set of stock fundamentals. Paying for more criteria will not decide which ones matter for your company.
Sources
5 referencesFrequently asked questions
Does Stock Rover have a free service?
Yes. Its official documentation describes a Free service and a trial of paid functionality. Do not assume that advanced screening or portfolio features remain available after a trial ends.
Is CSV export included in the Stock Rover trial?
The trial restrictions on the plans page exclude CSV export. Confirm the rules if exporting data is the main task you want to evaluate.
Is Stock Rover mainly for international company research?
Its detailed company research and screening focus on North American securities. Check the exact listing and data you need before paying for overseas research.
Helmbeam is a research and analysis tool operated by Scydex Ltd. Scydex Ltd is not authorised or regulated by the Financial Conduct Authority. Helmbeam does not provide investment advice, recommendations, or solicitations to buy or sell securities. All data is for informational purposes only. Past performance of any signal, cohort, or classification does not guarantee future results. All investing involves risk, including loss of principal. Always conduct your own research and consult a qualified financial adviser before making investment decisions.
Where Helmbeam fits
In Helmbeam, you can explore companies, inspect their business numbers and follow the ones you want to revisit. That suits a research shortlist without requiring it to be a record of your holdings. Stock Rover's documented portfolio-analysis tools address additional needs. Compare that distinction in Helmbeam versus Stock Rover before choosing a subscription.
Helmbeam is available as a free download on iOS and Android.
